您当前的位置：
首页 >
文章列表页 >
Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders
Short communication | 更新时间：2023-08-29

    • Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders

    • Genes & Diseases   Vol. 10, Issue 5, (2023)
    • 作者机构：

      1. Department of Nephrology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center,Zhejiang,Hangzhou,China,310052

      2. The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health,Zhejiang,Hangzhou,China,310052

      3. Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University,Beijing,China,100084

    • DOI：10.1016/j.gendis.2022.10.002    

      CLC：

    • Published：2023，

      Published Online：1 September 2023，

    扫 描 看 全 文

  • Yunfan Pan, Li Lin, Fan Yu, et al. Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders. [J]. Genes & Diseases 10(5).(2023) DOI： 10.1016/j.gendis.2022.10.002.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0